Medicare Drug Solution Rests In Low-Income Senior Rx Plans, Pfizer Says
Executive Summary
Prescription drug programs targeted at the 15% of seniors with low incomes could satisfy the political demands for a Medicare drug benefit, Pfizer suggested in post-election comments to securities analysts.